No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs5851123 |
chr3:98250078-98250079 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs397875850 |
chr3:98250081-98250082 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs76541666 |
chr3:98250149-98250150 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs34179940 |
chr3:98250150-98250151 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs56126006 |
chr3:98250173-98250174 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs147623467 |
chr3:98250181-98250182 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs142901579 |
chr3:98250197-98250198 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs563938074 |
chr3:98250199-98250200 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs148657909 |
chr3:98250202-98250203 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs4857399 |
chr3:98250215-98250216 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
11 |
rs376890440 |
chr3:98250382-98250383 |
Weak transcription Enhancers Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs556278144 |
chr3:98250410-98250411 |
Weak transcription Enhancers Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs576444770 |
chr3:98250453-98250454 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs117204961 |
chr3:98250505-98250506 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs142124631 |
chr3:98250535-98250536 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs187615152 |
chr3:98250558-98250559 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs151159854 |
chr3:98250569-98250570 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs192254861 |
chr3:98250594-98250595 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs577617028 |
chr3:98250640-98250641 |
Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs545800355 |
chr3:98250646-98250647 |
Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs546087326 |
chr3:98250720-98250721 |
Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs563089947 |
chr3:98250738-98250739 |
Weak transcription Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs140101017 |
chr3:98250779-98250780 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs548453533 |
chr3:98250822-98250823 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs369630244 |
chr3:98250852-98250853 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs201851410 |
chr3:98250861-98250862 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs3749260 |
chr3:98250862-98250863 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
28 |
rs184408398 |
chr3:98250875-98250876 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs570860091 |
chr3:98250898-98250899 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs539882177 |
chr3:98250899-98250900 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs369731261 |
chr3:98250908-98250909 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs145191023 |
chr3:98250910-98250911 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs199675530 |
chr3:98250919-98250920 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs569843256 |
chr3:98250923-98250924 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs562498362 |
chr3:98250925-98250926 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs145602713 |
chr3:98250929-98250930 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs145928800 |
chr3:98250950-98250951 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs373094519 |
chr3:98250955-98250956 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs376024326 |
chr3:98250965-98250966 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs201534903 |
chr3:98250971-98250972 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs2230344 |
chr3:98250986-98250987 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
42 |
rs534323108 |
chr3:98250999-98251000 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs114940458 |
chr3:98251000-98251001 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs147957406 |
chr3:98251038-98251039 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs374086937 |
chr3:98251049-98251050 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs145360341 |
chr3:98251064-98251065 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs149131823 |
chr3:98251071-98251072 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs377521784 |
chr3:98251082-98251083 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs151271302 |
chr3:98251086-98251087 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs569609883 |
chr3:98251091-98251092 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|